Sign In
Buy INSM
$106.92
-0.490 (-0.456%)
At Close: Jul 24, 2026
Insmed Incorporated (INSM) CEO Will Lewis on Q4 2020 Results - Earnings Call Transcript
02:21pm, Thursday, 25'th Feb 2021
Insmed Incorporated (INSM) CEO Will Lewis on Q4 2020 Results - Earnings Call Transcript
Insmed's Inhaled Treprostinil Palmitil Is Safe; Healthy Volunteers Study Show
08:37am, Friday, 19'th Feb 2021
Insmed Incorporated (NASDAQ: INSM) has announced topline results from the Phase 1 study evaluating treprostinil palmitil inhalation powder (TPIP) in healthy volunteers. The company plans to presen
Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil Inhalation Powder (TPIP)
07:30am, Friday, 19'th Feb 2021
BRIDGEWATER, N.J., Feb. 19, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, t
Top 10 Healthcare Stocks for the Future
06:44am, Sunday, 29'th Nov 2020
In this article we present the list of Top 10 Healthcare Stocks for the Future. Click to skip ahead and see the Top 5 Healthcare Stocks for the Future .
BRIDGEWATER, N.J., Nov. 13, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
Insmed Incorporated (INSM) CEO Will Lewis on Q3 2020 Results - Earnings Call Transcript
11:21pm, Thursday, 29'th Oct 2020
Insmed Incorporated (INSM) CEO Will Lewis on Q3 2020 Results - Earnings Call Transcript
Insmed Reports Third Quarter 2020 Financial Results and Provides Business Update
07:30am, Thursday, 29'th Oct 2020
BRIDGEWATER, N.J., Oct. 29, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
BRIDGEWATER, N.J., Oct. 28, 2020 /PRNewswire/ — Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
Nuveen Asset Management LLC Acquires 22,894 Shares of Insmed Incorporated (NASDAQ:INSM)
07:14am, Tuesday, 29'th Sep 2020
Nuveen Asset Management LLC boosted its holdings in Insmed Incorporated (NASDAQ:INSM) by 4.1% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commissi
OSI Systems Receives $4 Million Order to Provide Optical Sensors
12:30pm, Friday, 14'th Aug 2020
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Optoelectronics division has received an order for approximately $4 million from a leading defense electronic
Is OSI Systems, Inc.'s (NASDAQ:OSIS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
04:33pm, Tuesday, 11'th Aug 2020
OSI Systems' (NASDAQ:OSIS) stock is up by a considerable 14% over the past three months. As most would know...
OSI Systems, Inc.'s (NASDAQ:OSIS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
04:32pm, Tuesday, 11'th Aug 2020
OSI Systems' (NASDAQ:OSIS) stock is up by a considerable 14% over the past three months. As most would know...
OSI Systems Announces Fourth Quarter and Fiscal Year End Conference Call
12:30pm, Tuesday, 11'th Aug 2020
OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, August 20, 2020 at 1:30pm PT to discuss its results for the fourth quarter and fiscal year
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12:00pm, Friday, 07'th Aug 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
02:35pm, Thursday, 06'th Aug 2020
Insmed (INSM) delivered earnings and revenue surprises of -10.34% and 16.58%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
